CSBR Stock Summary and Trading Ideas (Champions Oncology | NASDAQ:CSBR)

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

What symbol and exchange does Champions Oncology shares trade?

Champions Oncology trades on the NASDAQ stock market under the symbol CSBR.

What is Champions Oncology stock price doing today?

As of March 16, 2026, CSBR stock price climbed to $6.25 with 6,544 million shares trading.

How much is Champions Oncology worth?

CSBR has a market cap of $86.79 million. This is considered a Micro Cap stock.

How much money does Champions Oncology make?

Last quarter Champions Oncology reported $17 million in Revenue and $.04 earnings per share. This fell short of revenue expectation by $-54,000 and missed earnings estimates by -$.05.

What is the highest and lowest price Champions Oncology traded in the last 3 year period?

In the last 3 years, CSBR traded as high as $11.99 and as low as $3.60.

What are the top ETFs holding Champions Oncology?

The top ETF exchange traded funds that CSBR belongs to (by Net Assets): VTI, VXF, IWC, DCOR, DFSU.

Is Champions Oncology (CSBR) a good investment?

CSBR has underperformed the market in the last year with a return of -29.7%, while the SPY ETF gained +22.6%. In the last 3 month period, CSBR fell short of the market, returning -7.0%, while SPY returned -1.6%. However, in the most recent 2 weeks CSBR has outperformed the stock market by returning +5.0%, while SPY returned -2.5%.

What are the support and resistance levels for Champions Oncology (CSBR)?

CSBR support price is $5.74 and resistance is $6.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CSBR shares will trade within this expected range on the day.